Wednesday, March 14, 2018 -- Valneva SE, a fully integrated commercial stage biotech company focused on developing innovative, lifesaving vaccines, announced the initiation of a Phase I clinical trial in the U.S. to evaluate the safety and immunogenicity of VLA1553, its live-attenuated vaccine candidate against Chikungunya. The Phase I clinical trial is a randomized, observer-blinded, dose-escalation, multi-center study. It will […] The post Chikungunya vaccine enters Phase I clinical trial appeared first on Outbreak News Today.
Saturday, April 28, 2018 -- PaxVax, a leading independent specialty vaccine company, announced today the enrollment of the first patient in its Phase 2b dose-finding trial of the chikungunya virus-like particle (VLP) vaccine, building upon a Phase 2a study by the National Institutes of Health (NIH) with 400 subjects. The Phase 2b study will enroll 400 subjects to evaluate multiple dosing regimens. PaxVax expects […] The post Chikungunya vaccine: PaxVax announces the initiation of Phase 2b Trial appeared first on Outbreak News Today.
Saturday, September 16, 2017 -- With an increase in the mosquito-borne viral infections caused by chikungunya in areas of Italy, the National Center for Blood (CNS) of the Higher Health Institute (ISS) suspended donations of blood and blood components in the municipality of Anzio and the Municipality of Rome, according to the health ministry (computer translated). Seventeen cases of the disease have […] The post Italy: Chikungunya prompts suspension of blood donations in Rome appeared first on Outbreak News Today.
Saturday, May 05, 2018 -- PaxVax, a leading independent specialty vaccine company, announced today that it has received Fast Track designation from the U.S. Food and Drug Administration (FDA) for its vaccine for the prevention of disease caused by the chikungunya virus. Chikungunya represents a significant public health need and can cause headache, muscle pain, and skin rashes, with severe, […] The post PaxVax Chikungunya vaccine receives FDA Fast Track designation appeared first on Outbreak News Today.
Tuesday, May 22, 2018 -- Scientists have identified a molecule found on human cells and some animal cells that could be a useful target for drugs against chikungunya virus infection and related diseases, according to new research published in the journal Nature. A team led by scientists at Washington University School of Medicine in St. Louis conducted the research, which was […] The post Chikungunya: Researchers identify target for treatment appeared first on Outbreak News Today.
Tuesday, August 22, 2017 -- French health officials reported two confirmed autochthonous chikungunya cases earlier this month, according to an ARS news release (computer translated). The cases were reported in the department of Var in Southern France. The first case who lives in Cannet-des-Maures in the Var district and works in the Alpes-Maritimes district had onset of symptoms on 1 August. The […] The post France reports two locally transmitted Chikungunya cases in the south appeared first on Outbreak News Today.
Wednesday, June 27, 2018 -- Provisional data from the Centers for Disease Control and Prevention (CDC) shows that through the first six months of 2018, 18 chikungunya cases were reported. All cases were imported, or occurred in travelers returning from affected areas. The cases were reported from 11 states– New York (5), Texas (3), New Jersey (2) and one each […] The post Chikungunya in the US, all cases imported appeared first on Outbreak News Today.
Friday, May 11, 2018 -- Fast Track program is designed to facilitate development and expedite review of therapies and vaccines to address unmet health needs... The post FDA grants fast track designation for a Chikungunya...
Monday, August 28, 2017 -- Lisa Schnirring | News Editor | CIDRAP NewsAug 28, 2017The number of people sickened in France's outbreak has grown from 2 to 13.
Friday, July 28, 2017 -- University of Florida scientists are starting to better understand the ability of two Florida mosquito species to transmit two strains of chikungunya virus that have caused outbreaks of human disease around the world.
Monday, May 07, 2018 -- If clinical development progresses, the PaxVax vaccine could potentially become the first vaccine approved by the FDA for the prevention of chikungunya.
Tuesday, August 15, 2017 -- Chikungunya virus is a mosquito-borne virus for which recent outbreaks in human populations have drawn a lot of interest from the scientific community. Luckily, a group of investigators recently reported the development of a monoclonal antibody with therapeutic potential in a macaque monkey model of the disease. Chikungunya virus (CHIKV) can be transmitted to […] The post Monoclonal Antibody Reduces Symptoms Associated with Chikungunya Virus Infection appeared first on Medical News Bulletin.
Thursday, May 17, 2018 -- Chikungunya virus is a growing threat to the United States and other regions of the world as the mosquito that carries the virus expands its reach. Telltale symptoms of chikungunya infection are fever and joint pain that last about a week.
Monday, June 11, 2018 -- Themis announced today that the European Medicines Agency has granted PRIority MEdicines designation to its most advanced program in development, a vaccine to prevent chikungunya fever.
Monday, August 21, 2017 -- Lisa Schnirring | News Editor | CIDRAP NewsAug 21, 2017In other developments, a few more cases were reported in the Americas and mosquito trials showed a risk of spread in major Kenyan cities.
Tuesday, May 08, 2018 -- MedicalResearch.com Interview with: Lisa Danzig, MD Chief Medical Office PaxVax MedicalResearch.com: Would you briefly explain what is meant by Chikungunya infection? Whom does it primarily affect? How is it transmitted and what the complications? Response: Chikungunya is caused by the chikungunya … Continue reading →
Tuesday, March 13, 2018 -- Valneva Initiates Phase I Clinical Study to Evaluate Its Single-Shot Vaccine Candidate against Chikungunya Lyon (France), March 13, 2018 - Valneva SE, a fully integrated commercial stage biotech company focused on...
Friday, May 04, 2018 -- There are currently no approved treatments or vaccines available for chikungunya, a virus transmitted through mosquito bites.
Tuesday, May 22, 2018 -- Scientists have identified a molecule found on human cells and some animal cells that could be a useful target for drugs against chikungunya virus infection and related diseases, according to new research published in the journal Nature.
Tuesday, March 20, 2018 -- Chikungunya virus has become a disease of global concern due to its potentially disabling consequences and its efficient transmission.